Microbial cells outnumber the human cells in the
ratio 10:1 in a health human body. Human microbiome is the study of
microbes present in the human body. These are beneficial microbes
that carry out functions not performed by any gene in the human DNA
and hence, they play a very important role in the human body. For
example, these microbes produce certain vitamins that our body cannot
make, breakdown our food, equip our immune system to recognize
harmful foreign bodies, and produce anti-inflammatory compounds
against it. The seemingly unending beneficial properties of microbial
population was unearthed in 2008, as part of the Human Microbiome
Project (HMP) launched by the National Institutes of Health (NIH).
The HMP project aims to characterize the human microbiome and analyze
its role in human health and disease conditions.
The HMP has identified microbiome communities at
several human body sites, including gastrointestinal tract, skin,
oral cavity, nasal passages, and urogenital tract. Currently, the HMP
projects are focused on three areas – pregnancy and preterm birth,
onset inflammatory bowel disease, and onset of type 2 diabetes.
Fill the form for an exclusive sample of Human
Microbiome Market report @
https://www.coherentmarketinsights.com/insight/request-sample/182
Global Human Microbiome Market Taxonomy
Research in this field has led to the emergence of
various microbiome-based products. The global human microbiome market
is analyzed on the basis of product type into probiotics, prebiotics,
foods, medial foods, diagnostic devices, and other drugs and
supplements. Prebiotics are increasing demand worldwide, with growing
awareness about the various beneficial properties of the product such
as improved digestion, better gut health, help with weight loss, and
reduced risk of heart disease.
On the basis of application, the global human
microbiome market is segmented into therapeutic and diagnostic.
Therapeutic use of human microbiome is increasing with research
yielding new applications and usage of human microbiome. The market
is thus expected to be inclining towards therapeutic applications in
near future. Moreover, microbiome products are considered to be
relatively safe, which creates a highly conducive environment for
growth of human microbiome industry.
The human microbiome can also be analyzed based on
the technology used for conducting research in this field. These
technologies include cell culture technology, high-throughput
technology, omics technology and computational tools. Products used
for research include instruments (analyzers and other laboratory
instruments) and consumables (kits and reagents).
Market participants can also understand the human
microbiome market dynamics through analysis for different health
conditions such as obesity, diabetes, acute diarrhea, mental
disorders, autoimmune disorders, cancer, and other diseases.
Request to view table of content @
https://www.coherentmarketinsights.com/ongoing-insight/toc/182
Human microbiome market: Regional overview
The human microbiome market is in growth stage and
is rapidly emerging, with promising future. The market is highly
developed in North America and Europe, where product and technology
is high among the consumers, researchers and healthcare
practitioners. Introduction of new products and microbiome modulators
in these regions would propel market growth. There is high interest
in incorporating microbiome modulators in food and dietary
supplements of human diet in order to supply the body with the
missing dietary supplements. The human microbiome technology and
products would gain significant traction in the emerging economies of
Asia Pacific, Latin America, and Middle East regions. Growing product
awareness, rising demand for safe medical products and increasing
research activities would be the driving factors for human microbiome
industry in these regions.
Some of the key players in the global human
microbiome market include Merck & Co. Inc., Affymetrix Inc.,
Vithera Pharmaceuticals, Microbiome Therapeutics, LLC, Vedanta
Biosciences, Inc., Metabiomics Corporation, Enterome Bioscience,
Osel, Inc., Yakult Honsha Co., Ltd., Second Genome, Inc. and E.I. Du
Pont De Nemours and Company
About Us:
Coherent Market Insights is a prominent market
research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment